After a dreadful 2024 that saw its stock lose more than 60% of its value, 2025 has started off as a better year for Walgreens ...

Walgreens' sale of its majority stake in primary and multispecialty care provider VillageMD is underway, CEO Tim Wentworth ...

Walgreens Boots Alliance Inc. reported quarterly sales that surpassed Wall Street’s expectations, spurring the shares to ...

The Bread of Healing Clinic is far more than just a health care provider—it’s a sanctuary of hope, compassion, and healing for the city’s most vulnerable residents.

Walgreens, like other companies in the retail pharmacy space, has struggled with challenges related to low reimbursement and ...

Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.

Revenue came to $39 billion for the fiscal quarter ended in November, driven by higher prices for branded drugs and ...

Q1 2025 Earnings Call Transcript January 10, 2025 Walgreens Boots Alliance, Inc. beats earnings expectations. Reported EPS is ...

Big-box drugstores like CVS and Walgreens are closing thousands of stores across the country, including some in the St. Louis ...

Looking forward, Walgreens Boots Alliance is maintaining its adjusted EPS (earnings per share) guidance for fiscal 2025 between $1.40 to $1.80. The company expects growth from its U.S. Healthcare and ...